Table 1.
Demographic and clinical characteristics of the study population.
| Variable | Infantile n = 22 | Adult n = 12 | P value |
|---|---|---|---|
| Gender | |||
| Male, n (%) | 12 (75.0) | 4 (25.0) | 0.236 |
| Female, n (%) | 10 (55.6) | 8 (44.4) | |
| Age | |||
| Symptomatology | 3 months (1 day to 11 months) | 32 months (12–123) |
|
| Diagnosis | 4 months (1 day to 11 months) | 36 months (12–126) |
|
| Family history, n (%) | 5 (22.7) | 2 (16.7) | 0.677 |
| Symptoms, n (%) | |||
| Tachypnea | 14 (63.4) | 3 (25.0) | 0.031 |
| Heart failure | 6 (27.3) | 2 (16.7) | 0.486 |
| Pneumonia | 5 (22.7) | 5 (41.7) | 0.247 |
| Cyanosis | 3 (13.6) | 2 (16.7) | 0.812 |
| Extracardiac anomalies, n (%) | 12 (54.5) | 7 (58.3) | 0.832 |
| Complicated ASD, n (%) | 16 (72.7) | 8 (66.7) | 0.077 |
| Cardiac anomalies excluding ASD, n (%) | 11 (50.0) | 3 (25.0) | 0.275 |
| PDA + VSD | 2 | ||
| PDA | 5 | 1 | |
| VSD | 1 | 1 | |
| DORV + VSD | 1 | ||
| TOF | 1 | ||
| VSD + CoA | 1 | ||
| VSD + RVOTO | 1 | ||
| APCs, n (%) | 19 (86.4) | 8 (66.7) | 0.211 |
| PH, n (%) | 14 (63.6) | 3 (25.0) | 0.035 |
| PVS, n (%) | 10 (45.5) | 1 (8.3) | 0.006 |
| Mortality, n (%) | 7 (31.8) | 0 (0) | 0.036 |
APCs, Aortopulmonary collateral arteries; PH, Pulmonary hypertension; PVS, Pulmonary vein stenosis; ASD, Atrial septal defect; PDA, Patent ductus arteriosus; VSD, Ventricular septal defect; DORV, Double outlet of right ventricle; TOF, Tetralogy of Fallot; CoA, Coarctation of aorta; RVOTO, Right ventricular outflow tract obstruction.